Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001771653-19-000001
Filing Date
2019-03-26
Accepted
2019-03-25 18:32:29
Documents
1
Effectiveness Date
2019-03-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7303
  Complete submission text file 0001771653-19-000001.txt   8327
Mailing Address 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address 953 INDIANA STREET SAN FRANCISCO CA 94107 415-885-7810
Alessa Therapeutics, Inc. (Filer) CIK: 0001771653 (see all company filings)

EIN.: 830762950 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-335630 | Film No.: 19703689